Skip to main content
Livermore
Livermore
ZHEN

Shay Capital LLC

SEC CIK
0001723643
Latest filing
Aug 14, 2026

The latest 13F from Shay Capital LLC covers Q2 2026 (filed Aug 14, 2026): 394 long positions worth $906.6M. The top 10 holdings make up 32.1% of the portfolio, and the largest is FTAI Aviation Ltd. (FTAI) at 6.9%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
159
Est. +$221.3M
Added
101
Est. +$172.3M
Reduced
110
Est. −$208.6M
Sold out
153
Est. −$117.5M

Top 5 holdings

Share of this quarter's portfolio value

  1. FTAIFTAI Aviation Ltd.
    6.9%$62.7MHistory
  2. CXWCoreCivic, Inc.
    6.0%$54.3MHistory
  3. PCTPureCycle Technologies, Inc.
    4.2%$37.6MHistory
  4. CELHCelsius Holdings, Inc.
    2.8%$25.1MHistory
  5. GLNGGolar LNG Ltd
    2.4%$21.7MHistory

Share of portfolio

Top 5 holdings and the other 389 positions, by share of portfolio value

  1. FTAI6.9%
  2. CXW6.0%
  3. PCT4.2%
  4. CELH2.8%
  5. GLNG2.4%
  6. Other 389 positions77.8%

Biggest buys

New and added positions, by estimated amount bought

  1. CXWCoreCivic, Inc.
    +$42.1MAddedHistory
  2. SPCXSpace Exploration Technologies Corp
    +$21.7MNewHistory
  3. FTAIFTAI Aviation Ltd.
    +$14.0MAddedHistory
  4. HONAHoneywell Aerospace Inc.
    +$11.3MNewHistory
  5. XPOFXponential Fitness, Inc.
    +$11.2MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. CXWCoreCivic, Inc.
    +4.91 pp1.1% → 6.0%History
  2. SPCXSpace Exploration Technologies Corp
    +2.39 pp0.0% → 2.4%History
  3. PCTPureCycle Technologies, Inc.
    +1.30 pp2.9% → 4.2%History
  4. HONAHoneywell Aerospace Inc.
    +1.24 pp0.0% → 1.2%History
  5. XPOFXponential Fitness, Inc.
    +1.14 pp0.9% → 2.1%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. NVDANVIDIA Corp
    −$37.1MReducedHistory
  2. MUMicron Technology Inc
    −$24.4MReducedHistory
  3. RKTRocket Companies, Inc.
    −$16.7MReducedHistory
  4. APTVAptiv PLC
    −$11.3MSold outHistory
  5. INTCIntel Corp
    −$10.0MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. NVDANVIDIA Corp
    −4.82 pp6.7% → 1.9%History
  2. RKTRocket Companies, Inc.
    −2.15 pp2.2% → 0.1%History
  3. APTVAptiv PLC
    −1.61 pp1.6% → 0.0%History
  4. TMOThermo Fisher Scientific Inc.
    −1.08 pp2.3% → 1.2%History
  5. XXITwenty One Capital, Inc.
    −1.04 pp1.0% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$906.6M
+$202.4M (+28.7%) vs. prior quarter
Positions
394
+6 vs. prior quarter
Top 10 concentration
32.1%
Top 10 as share of value
Turnover
40.5%
Q2 2026, one quarter
Average holding period
6.6 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $906.6M (Q2 2026)

Q1 2021: $358.9MQ2 2021: $421.7MQ3 2021: $314.5MQ4 2021: $266.2MQ1 2022: $277.6MQ2 2022: $193.7MQ3 2022: $200.1MQ4 2022: $164.0MQ1 2023: $241.2MQ2 2023: $284.1MQ3 2023: $337.4MQ4 2023: $257.1MQ1 2024: $341.1MQ2 2024: $359.3MQ3 2024: $339.0MQ4 2024: $408.2MQ1 2025: $343.3MQ2 2025: $438.9MQ3 2025: $552.2MQ4 2025: $619.8MQ1 2026: $704.1MQ2 2026: $906.6M
Q1 2021Q2 2026
13F filings of Shay Capital LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 2026394$906.6MFTAICXWPCTvs. Q1 2026SEC
Q1 2026May 15, 2026388$704.1MNVDAFTAIPCTvs. Q4 2025SEC
Q4 2025Feb 17, 2026383$619.8MFTAIMSFTPCTvs. Q3 2025SEC
Q3 2025Nov 14, 2025303$552.2MFTAIPCTAZvs. Q2 2025SEC
Q2 2025Aug 14, 2025257$438.9MFTAIPCTGEOvs. Q1 2025SEC
Q1 2025May 15, 2025241$343.3MGEOFTAIPCTvs. Q4 2024SEC
Q4 2024Feb 14, 2025244$408.2MGEOGLNGPCTvs. Q3 2024SEC
Q3 2024Nov 14, 2024244$339.0MPCTGLNGFTAIvs. Q2 2024SEC
Q2 2024Aug 14, 2024218$359.3MGLNGPCTBABAvs. Q1 2024SEC
Q1 2024May 15, 2024267$341.1MPCTGLNGTLYSvs. Q4 2023SEC
Q4 2023Feb 14, 2024202$257.1MBGCTLYSGLNGvs. Q3 2023SEC
Q3 2023Nov 14, 2023251$337.4MMSFTGLNGTLYSvs. Q2 2023SEC
Q2 2023Aug 14, 2023284$284.1MFTAITLYSPCTvs. Q1 2023SEC
Q1 2023May 15, 2023286$241.2MTLYSFTAIL Catterton Asia Acquisitionvs. Q4 2022SEC
Q4 2022Feb 14, 2023204$164.0MFTAIFar Peak Acquisition CorpTLYSvs. Q3 2022SEC
Q3 2022Nov 14, 2022247$200.1MCHNGDREBHVNvs. Q2 2022SEC
Q2 2022Aug 15, 2022273$193.7MSPYMKLArclight Clean Transition IIvs. Q1 2022SEC
Q1 2022May 16, 2022324$277.6MTSPYCZRvs. Q4 2021SEC
Q4 2021Feb 14, 2022321$266.2MHealthcare Realty Trust IncXLNXState Street SPDR S&P Biotech ETFvs. Q3 2021SEC
Q3 2021Nov 15, 2021322$314.5MGMBGCREKRvs. Q2 2021SEC
Q2 2021Aug 13, 2021358$421.7MHYREMXIMSCvs. Q1 2021SEC
Q1 2021Aug 13, 2021320$358.9MREKRGX Acquisition CorpParamount Global–SEC

13D and 13G filings

Companies where Shay Capital LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

10 companies, largest stake first.

Companies where Shay Capital LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
TLYSTilly's, Inc.13G/A14.84%3.39M shares+2.94 ppfrom 11.90%Feb 13, 20235 filingsAug 14, 2025SEC
LVTXLAVA Therapeutics NV13G9.90%2.60M sharesNewSep 26, 20251 filingSep 26, 2025SEC
NEUPNeuphoria Therapeutics Inc.13G7.30%171.6K sharesNewOct 31, 20251 filingOct 31, 2025SEC
RPTXRepare Therapeutics Inc.13G6.70%2.87M sharesNewJan 27, 20261 filingJan 27, 2026SEC
OKUROnKure Therapeutics, Inc.13G6.30%810.2K sharesNewMay 29, 20251 filingMay 29, 2025SEC
DMYYdMY Squared Technology Group, Inc.13G5.40%125.4K sharesNewOct 3, 20251 filingOct 3, 2025SEC
AZA2Z CUST2MATE Solutions Corp.13G5.20%2.33M sharesNewApr 9, 20261 filingApr 9, 2026SEC
XPOFXponential Fitness, Inc.13G5.20%2.16M sharesNewJun 1, 20261 filingJun 1, 2026SEC
CTRNCiti Trends Inc13G5.10%442.0K sharesNewApr 17, 20251 filingApr 17, 2025SEC
DUOTDuos Technologies Group, Inc.13G5.00%1.47M sharesNewMay 18, 20261 filingMay 18, 2026SEC

Latest filings

29 filings on file made by Shay Capital LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Shay Capital LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
XPOFXponential Fitness, Inc.Jun 1, 202611:47 AM ET13G5.20%2.16M sharesNewMay 22, 2026SEC
DUOTDuos Technologies Group, Inc.May 18, 202612:35 PM ET13G5.00%1.47M sharesNewMay 8, 2026SEC
AZA2Z CUST2MATE Solutions Corp.Apr 9, 20265:00 PM ET13G5.20%2.33M sharesNewApr 1, 2026SEC
RPTXRepare Therapeutics Inc.Jan 27, 20264:00 PM ET13G6.70%2.87M sharesNewJan 20, 2026SEC
NEUPNeuphoria Therapeutics Inc.Oct 31, 20254:00 PM ET13G7.30%171.6K sharesNewOct 24, 2025SEC
DMYYdMY Squared Technology Group, Inc.Oct 3, 20254:22 PM ET13G5.40%125.4K sharesNewSep 26, 2025SEC
LVTXLAVA Therapeutics NVSep 26, 20254:01 PM ET13G9.90%2.60M sharesNewSep 19, 2025SEC
TLYSTilly's, Inc.Aug 14, 20254:15 PM ET13G/A14.84%3.39M shares+2.94 ppfrom 11.90%Jun 30, 2025SEC
OKUROnKure Therapeutics, Inc.May 29, 20254:33 PM ET13G6.30%810.2K sharesNewMay 15, 2025SEC
TLYSTilly's, Inc.May 27, 20254:21 PM ET13G/A11.90%2.73M shares+1.92 ppfrom 9.98%May 22, 2025SEC
CTRNCiti Trends IncApr 17, 20252:03 PM ET13G5.10%442.0K sharesNewApr 11, 2025SEC
XELAExela Technologies, Inc.Feb 14, 20251:10 PM ET13G/A0.63%175.6K shares–Below 5%Dec 31, 2024SEC
TLYSTilly's, Inc.Feb 14, 20251:10 PM ET13G/A9.98%2.28M shares–Dec 31, 2024SEC
NVRONevro CorpFeb 14, 20251:09 PM ET13G/A4.19%1.57M shares–Below 5%Dec 31, 2024SEC
NVRONevro CorpDec 4, 202413GOld format–New–SEC
TLYSTilly's, Inc.Feb 14, 202413G/AOld format–––SEC
TBCHTurtle Beach CorpFeb 14, 202413G/AOld format–––SEC
GRPNGroupon, Inc.Feb 14, 202413G/AOld format–––SEC
XELAExela Technologies, Inc.Feb 14, 202413G/AOld format–––SEC
TBCHTurtle Beach CorpSep 29, 202313GOld format–––SEC